Literature DB >> 25326160

Defining a new role for the National Cancer Institute cooperative groups: more science, fewer trials.

Bruce A Chabner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25326160      PMCID： PMC4221382          DOI： 10.1634/theoncologist.2014-0359

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  2 in total

1.  Approval after phase I: ceritinib runs the three-minute mile.

Authors:  Bruce A Chabner
Journal:  Oncologist       Date:  2014-05-01

2.  Expanding public-private collaborations to enhance cancer drug development: a report of the Institute of Medicine's workshop series, "Implementing a National Cancer Clinical Trials System for the 21st Century".

Authors:  Monica M Bertagnolli; Renzo Canetta; Sharyl J Nass
Journal:  Oncologist       Date:  2014-10-17
  2 in total
  1 in total

Review 1.  Reflections on the Future of Pharmaceutical Public-Private Partnerships: From Input to Impact.

Authors:  Remco L A de Vrueh; Daan J A Crommelin
Journal:  Pharm Res       Date:  2017-06-06       Impact factor: 4.200
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.